Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $80.50 $93.35 Friday, 10th May 2024 BMRN stock ended at $81.03. This is 0.84% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 1.50% from a day low at $80.74 to a day high of $81.95.
90 days $80.50 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jan 04, 2017 $86.96 $87.52 $85.51 $86.87 1 339 058
Jan 03, 2017 $83.30 $86.57 $83.00 $85.84 1 286 931
Dec 30, 2016 $83.35 $83.74 $81.50 $82.84 1 258 820
Dec 29, 2016 $83.84 $84.71 $82.97 $83.35 811 445
Dec 28, 2016 $85.08 $86.59 $83.74 $84.15 927 558
Dec 27, 2016 $86.00 $87.61 $85.01 $85.08 655 453
Dec 23, 2016 $83.06 $86.00 $83.06 $85.66 715 875
Dec 22, 2016 $84.91 $85.21 $82.89 $83.54 987 954
Dec 21, 2016 $85.09 $86.68 $82.84 $85.05 1 712 427
Dec 20, 2016 $84.41 $85.42 $83.64 $84.98 660 177
Dec 19, 2016 $85.15 $85.91 $83.97 $84.38 925 325
Dec 16, 2016 $85.32 $86.40 $84.75 $85.36 1 987 247
Dec 15, 2016 $85.72 $86.10 $84.41 $85.35 1 285 872
Dec 14, 2016 $83.26 $85.61 $82.72 $85.58 1 402 901
Dec 13, 2016 $82.44 $84.36 $82.40 $83.44 1 129 954
Dec 12, 2016 $82.37 $82.75 $80.67 $82.01 1 277 915
Dec 09, 2016 $84.67 $87.52 $82.58 $82.68 1 843 224
Dec 08, 2016 $81.70 $83.72 $80.50 $83.51 1 121 380
Dec 07, 2016 $81.36 $82.34 $79.50 $81.02 1 806 512
Dec 06, 2016 $82.99 $83.48 $81.89 $82.99 1 378 001
Dec 05, 2016 $82.51 $84.59 $81.86 $82.45 1 677 063
Dec 02, 2016 $83.39 $84.02 $81.89 $82.21 1 138 268
Dec 01, 2016 $85.97 $86.46 $82.51 $83.33 1 177 587
Nov 30, 2016 $86.64 $87.90 $85.53 $85.63 1 440 296
Nov 29, 2016 $87.46 $88.00 $85.86 $86.70 1 112 485
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT